Comparison Overview
High-Content Imaging | Molecular Devices

High-Content Imaging | Molecular Devices
N/A
Last Update: 25/03/2026
We empower researchers with cutting-edge AI-driven high-content screening solutions, delivering deeper insights into complex biological models. Our innovative ImageXpress® HCS.ai High-Content Screening System and IN Carta® Image Analysis Software streamline workflows fo...

Thermo Fisher Scientific
168 Third Avenue, Waltham, MA, US
Last Update: 01/04/2026
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accele...
Compliance Ranges Comparison

High-Content Imaging | Molecular Devices







Thermo Fisher Scientific






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for High-Content Imaging | Molecular Devices in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Thermo Fisher Scientific in 2026.
Incident History - High-Content Imaging | Molecular Devices (X = Date, Y = Severity)
High-Content Imaging | Molecular Devices cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Thermo Fisher Scientific (X = Date, Y = Severity)
Thermo Fisher Scientific cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

High-Content Imaging | Molecular Devices

Thermo Fisher Scientific
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.